R. L. Stone

410 total citations · 1 hit paper
3 papers, 347 citations indexed

About

R. L. Stone is a scholar working on Infectious Diseases, Organic Chemistry and Pharmacology. According to data from OpenAlex, R. L. Stone has authored 3 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 1 paper in Infectious Diseases, 1 paper in Organic Chemistry and 1 paper in Pharmacology. Recurrent topics in R. L. Stone's work include Synthesis of Tetrazole Derivatives (1 paper), Click Chemistry and Applications (1 paper) and Synthesis and Characterization of Heterocyclic Compounds (1 paper). R. L. Stone is often cited by papers focused on Synthesis of Tetrazole Derivatives (1 paper), Click Chemistry and Applications (1 paper) and Synthesis and Characterization of Heterocyclic Compounds (1 paper). R. L. Stone collaborates with scholars based in United States and United Kingdom. R. L. Stone's co-authors include Neil W. Gibson, J A Slack, M. F. G. STEVENS, Daniel Chubb, C Goddard, J A Hickman, C. G. Culbertson, H. M. Powell, Donald C. DeLong and Irving S. Johnson and has published in prestigious journals such as Journal of Bacteriology, Annals of the New York Academy of Sciences and PubMed.

In The Last Decade

R. L. Stone

2 papers receiving 331 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine.

1987 335 citations M. F. G. STEVENS, J A Hickman et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. L. Stone United States	2	158	153	115	110	40	3	347
Kathy D. Knebel United States	10	130 0.8×	137 0.9×	93 0.8×	70 0.6×	84 2.1×	12	412
K. P. Hoyes United Kingdom	10	121 0.8×	121 0.8×	109 0.9×	46 0.4×	37 0.9×	13	364
Dagmar Bauer Germany	7	131 0.8×	197 1.3×	45 0.4×	72 0.7×	89 2.2×	8	541
Edmond-Philippe Malaise France	11	223 1.4×	31 0.2×	153 1.3×	256 2.3×	157 3.9×	12	664
Brian A. Staton United States	7	193 1.2×	88 0.6×	361 3.1×	214 1.9×	39 1.0×	7	501
Jewel Plummer Cobb United States	11	96 0.6×	18 0.1×	138 1.2×	74 0.7×	65 1.6×	21	329
J. Mestan Switzerland	5	194 1.2×	190 1.2×	95 0.8×	32 0.3×	37 0.9×	7	515
K Adams United Kingdom	10	132 0.8×	19 0.1×	133 1.2×	107 1.0×	95 2.4×	14	431
Geetha D. Vallabhaneni United States	4	275 1.7×	51 0.3×	274 2.4×	262 2.4×	49 1.2×	4	532
Kirk Douglas United States	10	66 0.4×	67 0.4×	68 0.6×	113 1.0×	107 2.7×	18	386

Countries citing papers authored by R. L. Stone

Since Specialization

Citations

This map shows the geographic impact of R. L. Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. L. Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. L. Stone more than expected).

Fields of papers citing papers by R. L. Stone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. L. Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. L. Stone. The network helps show where R. L. Stone may publish in the future.

Co-authorship network of co-authors of R. L. Stone

This figure shows the co-authorship network connecting the top 25 collaborators of R. L. Stone. A scholar is included among the top collaborators of R. L. Stone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. L. Stone. R. L. Stone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

STEVENS, M. F. G., J A Hickman, Daniel Chubb, et al.. (1987). Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine.. PubMed. 47(22). 5846–52. 335 indexed citations breakdown →

2.

Stone, R. L., Donald C. DeLong, R. N. Hull, & Irving S. Johnson. (1965). IN VIVOANDIN VITROINHIBITION OF HEPATITIS VIRUSES BY STREPTOTHRICIN. Annals of the New York Academy of Sciences. 130(1). 355–364. 1 indexed citations

3.

Stone, R. L., C. G. Culbertson, & H. M. Powell. (1956). STUDIES OF A BACTERIOPHAGE ACTIVE AGAINST A CHROMOGENIC NEISSERIA. Journal of Bacteriology. 71(5). 516–520. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact